Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression

Overview of attention for article published in Breast Cancer Research and Treatment, March 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,145 followers.

RT @Senology: #Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists https://t.co/ZSOk5PIlF4 #breast #…

Reply Repost Favourite

#Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists https://t.co/ZSOk5PIlF4 #breast #cancer

Reply Repost Favourite